Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
09/24/1998 | CA2283688A1 Serine/threonine protein kinase |
09/24/1998 | CA2282845A1 Methods and compositions for modulating responsiveness to corticosteroids |
09/23/1998 | EP0865431A2 Compounds |
09/23/1998 | EP0865430A1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists |
09/23/1998 | EP0865428A1 Vitamin d analogues |
09/23/1998 | EP0865419A1 Indane dimer compounds and their pharmaceutical use |
09/23/1998 | EP0711280B1 Perhydroisoindole derivatives as p substance antagonists |
09/23/1998 | CN1039908C Tricyclic diazepine vasopressin antagonists |
09/22/1998 | US5811562 Pharmceutical compositions for the treatment of osteoporosis, wound healing, transplant rejection, rheumatoid arthritis |
09/22/1998 | US5811553 Quinoline derivatives(2) |
09/22/1998 | US5811549 Process of preparing imidazole compounds |
09/22/1998 | US5811455 Compounds useful for treating allergic or inflammatory diseases |
09/22/1998 | US5811449 Administering a suppressor pyrrolidine dithiocarbamate to prevent the oxidation of a polyunsaturated fatty acid |
09/22/1998 | US5811444 Compositions for reducing abnormal stimulation of endothelin receptors and novel compounds |
09/22/1998 | US5811431 Treating or preventing pain, inflammation, migraine, emesis, postherpetic neuralgia |
09/22/1998 | US5811410 Nonsteroidal antiinflammatory drugs |
09/22/1998 | US5811406 Stabilized by adding cryoprotectant and lyophilizing; delivering to cell tissue |
09/22/1998 | US5811405 Pharmaceuticals, diagnostic agents |
09/22/1998 | CA2093797C Substituted imidazobenzazepines and imidazopyridoazepines |
09/21/1998 | CA2232787A1 Antiallergic agent having an anti-oxidant action |
09/17/1998 | WO1998040482A1 Growth factor receptor binding protein |
09/17/1998 | WO1998040382A1 Novel tetrazoles |
09/17/1998 | WO1998040370A1 Lta4 hydrolase inhibitors |
09/17/1998 | WO1998040364A1 Lta4 hydrolase inhibitors |
09/17/1998 | WO1998040079A1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
09/17/1998 | WO1998039970A1 Quinoline leukotriene antagonists |
09/17/1998 | WO1998024905A3 Secreted proteins and polynucleotides encoding them |
09/17/1998 | DE19711052A1 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agent |
09/17/1998 | CA2283296A1 Growth factor receptor binding protein |
09/17/1998 | CA2282710A1 Lta4 hydrolase inhibitors |
09/17/1998 | CA2282349A1 Lta4 hydrolase inhibitors |
09/16/1998 | EP0864653A1 Process for production of 4-(4-(4-(hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl)-alpha, alpha-dimethylphenyl acetic acid and phosphorylated derivatives |
09/16/1998 | EP0864323A1 Pharmaceutical preparation for oral application containing a histamine-immunoglobulin complex |
09/16/1998 | EP0864087A1 Combinatorial dihydrobenzopyran library |
09/16/1998 | EP0863992A1 Product and process to regulate actin polymerization |
09/16/1998 | EP0863915A1 ACYLATED ENOL DERIVATIVES OF $g(a)-KETOESTERS AND $g(a)-KETOAMIDES |
09/16/1998 | EP0863902A1 2'- 4'-HALO- 1,1'-BIPHENYL]-4-YL]METHYL]-5'-METHYL-SPIRO CYCLOPENTANE-1,7'(8'H)- 3H]IMIDAZO 2,1-b]PURIN]-4'(5'H)-ONES |
09/16/1998 | EP0863876A1 Quinoline derivatives containing a diol as leukotriene antagonists |
09/16/1998 | EP0863873A1 Indole carbamates as leukotriene antagonists |
09/16/1998 | EP0863768A2 Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
09/16/1998 | EP0810854A4 Aerosols containing beclomethazone nanoparticle dispersions |
09/16/1998 | EP0733047B1 Substituted oxazolidines with stimulating effect of beta-adrenergig receptor |
09/16/1998 | EP0728128B1 Substituted phenyl compounds |
09/16/1998 | EP0649432B1 Fluorine comprising dipeptides as inhibitors against human leucocyte elastase inhibitors |
09/16/1998 | CN1193325A Cell adhension inhibitors |
09/16/1998 | CN1193022A Heterocyclic compound used as leucocyte adherence inhibitor and VLA-4 antagonist |
09/16/1998 | CN1192929A Oral medicinal preparation |
09/16/1998 | CN1192909A Foot-bathing ointment of Chinese medicine |
09/15/1998 | US5808097 Proline derivatives |
09/15/1998 | US5808037 Oligomers which inhibit expression of collagen genes |
09/15/1998 | US5807886 Treatment of neurodegenerative disorders, migraine, drug addiction |
09/15/1998 | US5807884 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
09/15/1998 | US5807867 Quinuclidine derivatives |
09/15/1998 | US5807862 Therapeutic compounds containing pyrimidinyl moieties |
09/15/1998 | US5807829 Serine protease inhibitor--tripeptoid analogs |
09/15/1998 | US5807824 C5A receptor antagonists having substantially no agonist activity |
09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
09/11/1998 | WO1998039303A1 Small molecules useful in the treatment of inflammatory disease |
09/11/1998 | WO1998039023A1 Treatment of cardiomyopathy |
09/11/1998 | WO1998038995A1 Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent |
09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
09/11/1998 | CA2278547A1 Small molecules useful in the treatment of inflammatory disease |
09/09/1998 | EP0863208A2 Histidine Kinase polypeptides, polynucleotides encluding the same and use thereof |
09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
09/09/1998 | EP0862630A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
09/09/1998 | EP0862567A1 5-azabicyclo(3.1.0)hexylalkyl-2-piperidones and -glutarimides as neurokinin receptor antagonists |
09/09/1998 | EP0862552A1 Succinimide and maleimide cytokine inhibitors |
09/09/1998 | EP0862430A1 Anti-viral compounds |
09/09/1998 | EP0691966B1 Quinolines as type iv phosphodiesterase inhibitors |
09/09/1998 | EP0663828B1 Treating allergic rhinitis and asthma using (-) Cetirizine |
09/09/1998 | EP0454813B1 A casein fraction for therapeutic, prophylactic and/or diagnostic use in infections of the respiratory tract |
09/09/1998 | CN1192739A N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
09/09/1998 | CN1192687A Bacterial inhibition with an oligosaccharide compound |
09/09/1998 | CN1192686A Method of treatment for lung diseases using antisense oligonucleotides |
09/03/1998 | WO1998037919A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE IN THE TREATMENT OF LPS-ASSOCIATED DISORDERS |
09/03/1998 | WO1998037901A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
09/03/1998 | WO1998037896A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
09/03/1998 | WO1998037894A1 Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
09/03/1998 | WO1998016205A3 Stable glassy state powder formulations |
09/03/1998 | CA2282639A1 Treatment of eosinophil-associated pathologies, such as bronchial asthma, with synergistic combinations of glucocorticoids and a local anesthetics |
09/03/1998 | CA2281838A1 Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders |
09/03/1998 | CA2281567A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
09/02/1998 | EP0861850A1 Tumor necrosis related receptor, TR4 |
09/02/1998 | EP0861238A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
09/02/1998 | EP0861071A1 Benzamidoxime prodrugs as antipneumocystic agents |
09/02/1998 | CN1192201A N-(aroyl) glycine hydroxamic acid derivatives and related compounds |
09/02/1998 | CN1192158A Method of treatment for asthma |
09/02/1998 | CN1192147A Imidazole compounds |
09/02/1998 | CN1192146A 4,4-(disubstituted) cyclohexan-1-ols)-monomers and related compounds |
09/01/1998 | US5801180 Antiischemic agents and cardiovascular disorders |
09/01/1998 | US5801148 Serine protease inhibitors-proline analogs |
08/27/1998 | WO1998037079A1 N-heterocyclic derivatives as nos inhibitors |
08/27/1998 | WO1998037061A1 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
08/27/1998 | WO1998036747A1 Pharmaceutical composition |
08/27/1998 | WO1998024782A3 Substituted pyrimidine compounds and their use |
08/27/1998 | WO1998017814A3 Gene expression and delivery systems and uses |
08/27/1998 | WO1998013031A3 Medicinal aerosol formulations comprising budesonide |
08/26/1998 | EP0860506A1 Human protein kinase hYAKI (HOACF 72) |
08/26/1998 | EP0859834A2 A paf-acetylhydrolase and use in therapy |
08/26/1998 | EP0859787A1 G-protein coupled receptor hnfds78 |